Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529)

被引:9
作者
Yonekawa, Akiko [1 ]
Shimono, Nobuyuki [2 ,3 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan
[2] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka 8128582, Japan
[3] Kyushu Univ Hosp, Ctr Study Global Infect, Fukuoka 8128582, Japan
来源
BIOLOGY-BASEL | 2022年 / 11卷 / 03期
关键词
SARS-CoV-2; COVID-19; diabetes; hyperinflammation; hyperglycemia; new-onset diabetes; Omicron variant; SARS CORONAVIRUS; HOSPITALIZED-PATIENTS; FUNCTIONAL RECEPTOR; INSULIN-TREATMENT; TYPE-2; RISK; MORTALITY; OUTCOMES; ACE2; ASSOCIATION;
D O I
10.3390/biology11030400
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary Amidst the dual pandemics of diabetes and coronavirus disease 2019 (COVID-19), with the constant emergence of novel variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a vicious cycle has been created, i.e., a hyperglycemic state contributes to the severe clinical course of COVID-19, which in turn has deleterious effects on glycometabolism and in some cases causes new-onset diabetes. Here, we present a comprehensive review of the current literature on the clinical and experimental findings associated with the interrelationship between diabetes and COVID-19. To control disease outcomes and glucometabolic complications in COVID-19, this issue is still being investigated. The coronavirus disease 2019 (COVID-19) global pandemic, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains uncontrolled, with the spread of emerging variants. According to accumulating evidence, diabetes is one of the leading risk factors for a severe COVID-19 clinical course, depending on the glycemic state before admission and during COVID-19 hospitalization. Multiple factors are thought to be responsible, including an altered immune response, coexisting comorbidity, and disruption of the renin-angiotensin system through the virus-host interaction. However, the precise underlying mechanisms remain under investigation. Alternatively, the focus is currently on the diabetogenic and ketosis-prone potential of SARS-CoV-2 itself, even for probable triggers of stress and steroid-induced hyperglycemia in COVID-19. In this article, we present a comprehensive review of the recent literature on the clinical and experimental findings associated with diabetes and COVID-19, and we discuss their bidirectional relationship, i.e., the risk for an adverse prognosis and the deleterious effects on glycometabolism. Accurate assessments of the incidence of new-onset diabetes induced by COVID-19 and its pathogenicity are still unknown, especially in the context of the circulation of SARS-CoV-2 variants, such as Omicron (B.1.1.529), which is a major challenge for the future.
引用
收藏
页数:18
相关论文
共 149 条
[1]   Characteristics and outcomes ofCOVID-19 in hospitalized patients with and without diabetes [J].
Al-Salameh, Abdallah ;
Lanoix, Jean-Philippe ;
Bennis, Youssef ;
Andrejak, Claire ;
Brochot, Etienne ;
Deschasse, Guillaume ;
Dupont, Herve ;
Goeb, Vincent ;
Jaureguy, Maite ;
Lion, Sylvie ;
Maizel, Julien ;
Moyet, Julien ;
Vaysse, Benoit ;
Desailloud, Rachel ;
Ganry, Olivier ;
Schmit, Jean-Luc ;
Lalau, Jean-Daniel .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (03)
[2]   Cytokine secretion in long-standing diabetes mellitus type 1 and 2: Associations with low-grade systemic inflammation [J].
Alexandraki, Krystallenia I. ;
Piperi, Christina ;
Ziakas, Panayiotis D. ;
Apostolopoulos, Nikolaos V. ;
Makrilakis, Konstantinos ;
Syriou, Vassiliki ;
Diamanti-Kandarakis, Evanthia ;
Kaltsas, Gregory ;
Kalofoutis, Anastasios .
JOURNAL OF CLINICAL IMMUNOLOGY, 2008, 28 (04) :314-321
[3]   Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection [J].
Allard, Robert ;
Leclerc, Pascale ;
Tremblay, Claude ;
Tannenbaum, Terry-Nan .
DIABETES CARE, 2010, 33 (07) :1491-1493
[5]   Alveolar Gas Exchange and Pulmonary Functions in Patients with Type II Diabetes Mellitus [J].
Anandhalakshmi, S. ;
Manikandan, S. ;
Ganeshkumar, P. ;
Ramachandran, C. .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (09) :1874-1877
[6]   Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series [J].
Armeni, Eleni ;
Aziz, Umaira ;
Qamar, Sulmaaz ;
Nasir, Sadia ;
Nethaji, Chidambaram ;
Negus, Rupert ;
Murch, Nicholas ;
Beynon, Huw Clarke ;
Bouloux, Pierre ;
Rosenthal, Miranda ;
Khan, Sidrah ;
Yousseif, Ahmed ;
Menon, Ravi ;
Karra, Efthimia .
LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (08) :660-663
[7]   Endothelial Dysfunction in Diabetes The role of reparatory mechanisms [J].
Avogaro, Angelo ;
Albiero, Mattia ;
Menegazzo, Lisa ;
de Kreutzenberg, Saula ;
Fadini, Gian Paolo .
DIABETES CARE, 2011, 34 :S285-S290
[8]  
Barrett CE, 2022, MMWR-MORBID MORTAL W, V71, P59, DOI 10.15585/mmwr.mm7102e2
[9]   Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study [J].
Barron, Emma ;
Bakhai, Chirag ;
Kar, Partha ;
Weaver, Andy ;
Bradley, Dominique ;
Ismail, Hassan ;
Knighton, Peter ;
Holman, Naomi ;
Khunti, Kamlesh ;
Sattar, Naveed ;
Wareham, Nicholas J. ;
Young, Bob ;
Valabhji, Jonathan .
LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (10) :813-822
[10]   Adipocytes, Innate Immunity and Obesity: A Mini-Review [J].
Blaszczak, Alecia M. ;
Jalilvand, Anahita ;
Hsueh, Willa A. .
FRONTIERS IN IMMUNOLOGY, 2021, 12